March 27, 2025
Junshi Biosciences Announces Toripalimab’s Approval in Singapore
SHANGHAI, March 26, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
Pharmaceuticals, Biotechnology and Life Sciences
SHANGHAI, March 26, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating…
Receives Court Approval for First Day Motions to Support Ongoing Business OperationsSAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) — 23andMe…
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million,…
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million,…
First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome Management to host conference call and webcast today, March…
Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – March 26, 2025 – 10:05…
NEW YORK and LEAMINGTON, Ontario, March 26, 2025 (GLOBE NEWSWIRE) — Tilray Brands Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), and…
Monrovia, CA , March 26, 2025 (GLOBE NEWSWIRE) — eXoZymes Inc. (NASDAQ: EXOZ) [“eXoZymes”] – a pioneer of AI-engineered enzymes…